Distinguished guests joined faculty and staff of the Department of Ophthalmology and Visual Sciences for an Investiture Ceremony recognizing the department’s commitment to ophthalmic education and vision research. Three faculty accepted endowed positions created through the generosity of grateful...
News
Iowa Eye Alumni Reception Join University of Iowa alumni and colleagues for food, drinks, and a great view of "The Windy City"! When: Sunday, October 16, 2016 | 6:30 PM to 9:30 PM Where: Swissotel Chicago - Edelweiss Penthouse 323 East Upper Wacker Drive - 43rd Floor RSVP to 319-384-8529 or joe-...
Dr. Drack will head a task force within AAPOS with the goal of educating pediatric ophthalmologists about genetic testing and gene therapy, and learning from pediatric ophthalmologists across the country how best to assist them with the evaluation of their genetic eye disease patients.
Ian Han, MD, joins the Retina and Vitreous Service as an assistant professor of ophthalmology.
A team of UI and VA researchers recently published its work on infusing stem cells to help restore proper drainage for fluid-clogged eyes at risk for glaucoma
With over 32,000 students, the University of Iowa is one of the nation's top public research universities, a member of the Big Ten conference since 1899, and an Association of American Universities member since 1909. Video of Health Care Undergraduate Research at the University of Iowa
The data in this study data suggest that peripheral retinal cryoablation therapy is an effective treatment for active pars planitis and may be better than conventional regional corticosteroid injections and oral corticosteroid therapy for induction of remission.
Wednesday, June 22, 2016 Ophthalmologists and alumni from across the country and around the globe returned to the University of Iowa for the 2016 Iowa Eye Annual Meeting and Alumni Reunion. The educational program featured several named lectures delivered by Drs. Lisa Brothers Arbisser, Jane Bailey...
Friday, June 17, 2016 University of Iowa retinal specialists are leading the first randomized, controlled phase III gene therapy trial involving patients with RPE65 mutation-associated inherited retinal dystrophies. The study is investigating treatment with adeno-associated viral vector delivery of...
Tuesday, October 27, 2015 IVR investigators have reported the discovery of a new genetic cause of retinitis pigmentosa. The gene TRNT1 is responsible for adding the CCA nucleotides to the 3' of tRNAs, and is therefore essential for translation of messenger RNAs into proteins. Severe genotypes in...